Impact of a Cueing Device on Upper Extremity Muscle Strength in Swimmers

NCT06923930 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2026-04-13

No results posted yet for this study

Summary

The goal of this study is to find out if a tool called an external cueing device (ECD) can help young swimmers improve their shoulder function. An ECD is a tool that limits arm movement and gives the swimmer a target to focus on while doing exercises. The main questions this study will answer are:

* Does using an ECD during certain exercises improve muscle strength?
* Does using an ECD while exercising help with shoulder stability?

Participants will:

* Test their shoulder muscle strength and stability at the beginning of the study.
* Complete 8 exercises as part of their regular dry-land training program for 6 weeks.
* Repeat the same tests after 3 weeks and again at the end of the study.

Conditions

  • Healthy Volunteers Only

Interventions

DEVICE

External Cueing Device

A portable product that provides movement pattern constraints to ensure improved exercise form, and provides a target zone for exercise effort

OTHER

Exercise

Shoulder stabilization exercise protocol contains 8 exercises ("I", "Y", "T", "i", "w", alternating arm "I"/"i", "n", and supine serratus punch) completed for 8 repetitions each for 3 weeks, and in weeks 4-6 completed at 2 sets of 8 repetitions each.

Sponsors & Collaborators

  • University of South Alabama

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
11 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-20
Primary Completion
2025-07-25
Completion
2025-07-25

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06923930 on ClinicalTrials.gov